z-logo
open-access-imgOpen Access
Induction of an epitope‐specific humoral immune response by lipopeptide–hapten conjugates: enhancement of the anti‐melittin response by a synthetic T helper (T h )‐cell epitope
Author(s) -
Hoffmann Petra,
Loleit Manuel,
Mittenbühler Klaus,
Beck Werner,
Wiesmüller KarlHeinz,
Jung Günther,
Bessler Wolfgang G
Publication year - 1997
Publication title -
fems immunology & medical microbiology
Language(s) - English
Resource type - Journals
eISSN - 1574-695X
pISSN - 0928-8244
DOI - 10.1111/j.1574-695x.1997.tb01016.x
Subject(s) - melittin , epitope , lipopeptide , biology , immune system , hapten , immunology , antigen , peptide , biochemistry , genetics , bacteria
Lipopeptides of bacterial origin constitute potent immunoadjuvants when combined with antigens. After the immunization with lipopeptides covalently coupled to non‐immunogenic low‐molecular‐mass antigens or haptens, a hapten‐specific humoral immune response can often be obtained. The response against synthetically prepared melittin fragments was further enhanced by the additional introduction of a T helper (T h )‐cell epitope into the lipopeptide–hapten conjugate. The T h ‐cell epitope applied, which is presented by the MHC class II molecule of the BALB/c (H‐2 d ) haplotype, consisted of a synthetic 16‐amino‐acid oligopeptide derived from sperm whale myoglobin. The immune‐enhancing effect was most pronounced for the melittin‐derived peptide fragments [Mel(1–16)] and [Mel(17–26)‐CONH 2 ]. Antibodies obtained after 3 immunizations with the conjugates recognized the synthetic as well as the native melittin molecule. Our results show that it is possible to markedly enhance a weak hapten‐specific immune response by coupling the haptens to a lipopeptide conjugated to a haplotype‐specific T helper‐cell epitope. The novel conjugates are well suited for the optimization of immunization procedures, and for the development of novel synthetic vaccines.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here